Navigation Links
Plasma protein Therapies Association Focuses Attention on Donors and Facilities
Date:8/19/2009

Texas Lawmakers Proclaimed August as "Plasma Protein Therapies Month"

Texas (Vocus) August 19, 2009 -- The contributions of voluntary plasma donors and the issue of treating critically ill patients with plasma protein therapies was recognized by Texas lawmakers in June when they proclaimed August "Plasma Protein Therapies Month" in the Lone Star State.

"Patients requiring plasma protein therapies have serious diseases and disorders and need to be assured that they will continue to have access to those treatments," said Josh Penrod, Vice President, Source for the Plasma Protein Therapy Association. "The collection of high-quality plasma from dedicated donors, like those in Texas, is a crucial component in the production of these therapies."

Plasma protein therapies include a treatment for primary immunodeficiency diseases, alpha-1 antitrypsin deficiency, also known as genetic emphysema, and for blood clotting disorders such as hemophilia. In addition, a plasma protein therapy is used in critical care settings, when treating severe trauma, burns and during major surgery. Plasma protein therapies refer to plasma-derived therapies and their recombinant analogs.

Hundreds of Texans each year donate plasma at 48 collection centers in Texas to help create therapies that save the lives of thousands of people across the nation. In fact, Texas has the most plasma donation centers in the nation.

This recognition raises awareness of the rare, genetic diseases treated with the therapies and to honor plasma donors across the state for their contributions to the little known treatments that benefit patients with a variety of genetic diseases and those in critical care settings including trauma and major surgery.

The Plasma Protein Therapies Association, a trade association representing plasma protein therapy manufacturers and the source plasma collection industry.

For more information about plasma protein therapies the diseases they treat and donating plasma, please go to www.donatingplasma.org or www.pptaglobal.org.

The Plasma Protein Therapeutics Association (PPTA) is the trade association and standard setting organization for the world's major producers of plasma derived and recombinant analog therapies (collectively, "plasma protein therapies"). These therapies are used by more than 1 million people worldwide each year to treat a variety of diseases and serious medical conditions. PPTA members produce over 80 percent of the plasma therapies for the United States market and more than 60 percent worldwide. Some of the critical therapies produced by PPTA members include: blood clotting factors for people with hemophilia, immune globulin intravenous used to prevent infections in people with immune deficiencies and other serious conditions, and alpha 1 proteinase inhibitor used to treat people with alpha 1 antitrypsin deficiency, also known as genetic emphysema.

Contacts:
Kym H. Kilbourne
(443) 458 4682
(443) 995-2102 (cellular)

Kara Flynn
(443) 458-4669
(443) 370-1177

###

Read the full story at http://www.prweb.com/releases/plasma_donor/Plasma_Protein_Therapy/prweb2766454.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Studies Find Plasma Disc Decompression Effective for Contained Disc Herniation
2. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
3. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
4. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
5. Toxoplasma infection increases risk of schizophrenia, study suggests
6. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
7. Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars
8. China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
9. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
10. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
11. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 22, 2017 , ... The National Academy of Certified Care ... April 2017 testing period. NACCM, a nonprofit organization, has provided the premier certification ... is periodically re-calibrated to ensure that newly certified professionals are prepared to work ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... Doctors ... recent addition of esteemed ophthalmologist, Dr. Steven H. Rauchman, practicing at North Valley ... in auto accidents, product liability, premise liability and other personal injury cases. These ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Global Endoscopy Market is poised to grow ... reach approximately $47.6 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
(Date:2/23/2017)... Ga., Feb. 23, 2017  MiMedx Group, Inc. (NASDAQ: ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, ... and full year ended December 31, 2016. ... Revenue is a 31% increase over full year 2015 ...
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
Breaking Medicine Technology: